Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1-expressing primary afferents by μ-opioid receptor activation-enkephalin in the spinal cord

Journal of Pharmacology and Experimental Therapeutics

Volumn 327, Issue 2, 2008, Pages 375-382

  Zhou, Hong Yi ^a   Chen, Shao Rui ^a   Chen, Hong ^a   Pan, Hui Lin ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENKEPHALIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GLUTAMIC ACID; MU OPIATE RECEPTOR AGONIST; NALOXONE; RESINIFERATOXIN; VANILLOID RECEPTOR 1;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; MALE; NEUROTRANSMITTER RELEASE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN THRESHOLD; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL CORD DORSAL HORN; SPINAL GANGLION;

ANIMALS; DITERPENES; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; MALE; NALOXONE; PAIN THRESHOLD; PLANT LECTINS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; TRPV CATION CHANNELS;

EID: 54349128395     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.141226     Document Type: Article

References (32)

1. Abbadie C, Lombard MC, Besson JM, Trafton JA, and Basbaum AI (2002) Mu and delta opioid receptor-like immunoreactivity in the cervical spinal cord of the rat after dorsal rhizotomy or neonatal capsaicin: an analysis of pre- and postsynaptic receptor distributions. Brain Res 930:150-162.
2. Blackmer T, Larsen EC, Bartleson C, Kowalchyk JA, Yoon EJ, Preininger AM, Alford S, Hamm HE, and Martin TF (2005) G protein betagamma directly regulates SNARE protein fusion machinery for secretory granule exocytosis. Nat Neurosci 8:421-425.
3. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, and Caron MG (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408:720-723.
4. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, and Lin FT (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286:2495-2498.
5. Bradaïa A, Berton F, Ferrari S, and Lüscher C (2005) beta-Arrestin2, interacting with phosphodiesterase 4, regulates synaptic release probability and presynaptic inhibition by opioids. Proc Natl Acad Sci U S A 102:3034-3039.
6. Capogna M, Gähwiler BH, and Thompson SM (1993) Mechanism of mu-opioid receptor-mediated presynaptic inhibition in the rat hippocampus in vitro. J Physiol 470:539-558.
7. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, and Julius D (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288:306-313.
8. Celver J, Xu M, Jin W, Lowe J, and Chavkin C (2004) Distinct domains of the mu-opioid receptor control uncoupling and internalization. Mol Pharmacol 65:528-537.
9. Chen SR and Pan HL (2006a) Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids. Brain Res 1081:119-125.
10. Chen SR and Pan HL (2006b) Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia. J Neurophysiol 95:3086-3096.
11. Chen SR, Prunean A, Pan HM, Welker KL, and Pan HL (2007) Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons. Neuroscience 145:676-685.
12. Cui M, Honore P, Zhong C, Gauvin D, Mikusa J, Hernandez G, Chandran P, Gomtsyan A, Brown B, Bayburt EK, et al. (2006) TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci 26:9385-9393.
13. Fields HL, Emson PC, Leigh BK, Gilbert RF, and Iversen LL (1980) Multiple opiate receptor sites on primary afferent fibres. Nature 284:351-353.
14. Gerachshenko T, Blackmer T, Yoon EJ, Bartleson C, Hamm HE, and Alford S (2005) Gbetagamma acts at the C terminus of SNAP-25 to mediate presynaptic inhibition. Nat Neurosci 8:597-605.
15. Ikeda K, Kobayashi T, Kumanishi T, Niki H, and Yano R (2000) Involvement of G-protein-activated inwardly rectifying K (GIRK) channels in opioid-induced analgesia. Neurosci Res 38:113-116.
16. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
17. Kohno T, Kumamoto E, Higashi H, Shimoji K, and Yoshimura M (1999) Actions of opioids on excitatory and inhibitory transmission in substantia gelatinosa of adult rat spinal cord. J Physiol 518:803-813.
18. Light AR and Willcockson HH (1999) Spinal laminae I-II neurons in rat recorded in vivo in whole cell, tight seal configuration: properties and opioid responses. J Neurophysiol 82:3316-3326.
19. Magnuson DS and Dickenson AH (1991) Lamina-specific effects of morphine and naloxone in dorsal horn of rat spinal cord in vitro. J Neurophysiol 66:1941-1950.
20. Marker CL, Luján R, Colón J, and Wickman K (2006) Distinct populations of spinal cord lamina II interneurons expressing G-protein-gated potassium channels. J Neurosci 26:12251-12259.
21. Marker CL, Luján R, Loh HH, and Wickman K (2005) Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids. J Neurosci 25:3551-3559.
22. Molliver DC, Radeke MJ, Feinstein SC, and Snider WD (1995) Presence or absence of TrkA protein distinguishes subsets of small sensory neurons with unique cytochemical characteristics and dorsal horn projections. J Comp Neurol 361:404-416.
23. Narita M, Mizoguchi H, Suzuki T, Narita M, Dun NJ, Imai S, Yajima Y, Nagase H, and Tseng LF (2001) Enhanced mu-opioid responses in the spinal cord of mice lacking protein kinase Cgamma isoform. J Biol Chem 276:15409-15414.
24. Pan HL, Khan GM, Alloway KD, and Chen SR (2003) Resiniferatoxin induces paradoxical changes in thermal and mechanical sensitivities in rats: mechanism of action. J Neurosci 23:2911-2919.
25. Rusin KI and Moises HC (1995) mu-Opioid receptor activation reduces multiple components of high-threshold calcium current in rat sensory neurons. J Neurosci 15:4315-4327.
26. Schneider SP, Eckert WA 3rd, and Light AR (1998) Opioid-activated postsynaptic, inward rectifying potassium currents in whole cell recordings in substantia gelatinosa neurons. J Neurophysiol 80:2954-2962.
27. Walker KM, Urban L, Medhurst SJ, Patel S, Panesar M, Fox AJ, and McIntyre P (2003) The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 304:56-62.
28. Woodbury CJ, Ritter AM, and Koerber HR (2000) On the problem of lamination in the superficial dorsal horn of mammals: a reappraisal of the substantia gelatinosa in postnatal life. J Comp Neurol 417:88-102.
29. 2+ channel currents to a mu opioid in isolectin B4-positive and -negative dorsal root ganglion neurons. J Pharmacol Exp Ther 311:939-947.
30. Yaksh TL and Noueihed R (1985) The physiology and pharmacology of spinal opiates. Annu Rev Pharmacol Toxicol 25:433-462.
31. Zhang HM, Chen SR, and Pan HL (2007) Regulation of glutamate release from primary afferents and interneurons in the spinal cord by muscarinic receptor subtypes. J Neurophysiol 97:102-109.
32. Zhou HY, Zhang HM, Chen SR, and Pan HL (2007) Increased nociceptive input rapidly modulates spinal GABAergic transmission through endogenously released glutamate. J Neurophysiol 97:871-882.